June 8, 2009 – CIVCO Medical Solutions announces needle guidance compatibility with GE Healthcare’s new 3Sp and 5Sp transducers. CIVCO’s Ultra-Pro II needle guidance system utilizes a two-part system consisting of a custom reusable biopsy bracket and a disposable snap-on needle guide. The single-use design of the needle guide reduces the risk of cross-contamination. Together, these tools offer physicians reduced technique variability, a shorter learning curve and reduced procedure time. The Ultra-Pro II needle guidance system is designed to increase the productivity of ultrasound-guided procedures including tissue biopsy, fluid aspirations, catheter placement and regional anesthesia. In addition, multi-angle brackets offer professionals several needle paths to reach the targeted anatomy during puncture procedures.

The Ultra-Pro II needle guide snaps securely onto the multi-angle bracket incorporating more flexibility and advanced features to increase productivity during ultrasound-guided procedures. The needle guide directs instruments according to on-screen software guidelines and holds the needle as it is advanced, providing a smooth insertion, while allowing you to see what you puncture. The Ultra-Pro II also features a larger tab for simple quick-release function, allowing easy detachment of the needle from transducer. Easy-to-read gauge sizes on the inserts make it simple to identify and alter gauge sizes in a darkened ultrasound suite. The guide also features a larger funnel for instrument insertion and will accept a full range of sizes including: 8.5FR, 14-23GA (19GA not available).

For more information: www.civco.com


Additional Content

News | Breast Biopsy Systems

July 7, 2021 — GE Healthcare announced the installation of Serena Bright in five hospitals and radiology centers around ...

Time July 07, 2021
arrow
News | Breast Imaging

January 4, 2021 — Hologic, Inc. announced it has completed the acquisition of SOMATEX Medical Technologies GmbH, a ...

Time January 04, 2021
arrow
News | Prostate Cancer

According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their lifetime. It’s both the second most common cancer and second most common cause of cancer death in American men. Early detection is critical and can increase a man’s chances of survival.

Time August 20, 2019
arrow
News | Biopsy Systems

Dune Medical Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy device which leverages the real-time tissue characterization capability of its radiofrequency (RF) spectroscopy technology.

Time March 29, 2019
arrow
Technology | Interventional Radiology

The U.S. Food and Drug Administration (FDA) cleared the Ion endoluminal system from Intuitive Surgical Inc. to enable minimally invasive biopsy in the peripheral lung.

Time February 20, 2019
arrow
Subscribe Now